Krishna Institute of Medical Sciences Limited (KIMS) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹723.05 (-1.59% day change)
Key ratios
- P/E ratio
- 119.91
- P/B ratio
- 11.07
- ROE (%)
- 10.74
- ROCE (%)
- 7.96
- Debt/Equity
- 1.89
- Dividend yield (%)
- 0
- Market cap (₹ Cr)
- 30,368.53
Forensic checks
Piotroski F-Score: 4/9 · Altman Z-Score: 3.9 · Beneish M-Score: -2.06
InvestSights quality score
45.6/100 — Below Average (descriptive data-driven composite; not a recommendation)
Latest earnings call (Q1 FY27)
AI summary: The single most important signal from this concall is the faster-than-expected ramp-up across KIMS' recently commissioned hospitals, most visibly at the new Kondapur facility (₹45 crore revenue in its first full month of July, versus a prior run-rate of ~₹32–33 crore at the old facility) and at Mahadevapura (EBITDA breakeven achieved in under seven months). Combined with…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.